Cargando…
Increased FGF1-FGFRc expression in idiopathic pulmonary fibrosis
BACKGROUND: Recent clinical studies show that tyrosine kinase inhibitors slow the rate of lung function decline and decrease the number of acute exacerbations in patients with Idiopathic Pulmonary Fibrosis (IPF). However, in the murine bleomycin model of fibrosis, not all tyrosine kinase signaling i...
Autores principales: | MacKenzie, BreAnne, Korfei, Martina, Henneke, Ingrid, Sibinska, Zaneta, Tian, Xia, Hezel, Stefanie, Dilai, Salma, Wasnick, Roxana, Schneider, Beate, Wilhelm, Jochen, El Agha, Elie, Klepetko, Walter, Seeger, Werner, Schermuly, Ralph, Günther, Andreas, Bellusci, Saverio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4495640/ https://www.ncbi.nlm.nih.gov/pubmed/26138239 http://dx.doi.org/10.1186/s12931-015-0242-2 |
Ejemplares similares
-
The ageing lung under stress
por: Korfei, Martina, et al.
Publicado: (2020) -
Characterization of a Novel Fibroblast Growth Factor 10 (Fgf10) Knock-In Mouse Line to Target Mesenchymal Progenitors during Embryonic Development
por: El Agha, Elie, et al.
Publicado: (2012) -
Regulation and role of the ER stress transcription factor CHOP in alveolar epithelial type-II cells
por: Klymenko, Oleksiy, et al.
Publicado: (2019) -
Differential LysoTracker Uptake Defines Two Populations of Distal Epithelial Cells in Idiopathic Pulmonary Fibrosis
por: Wasnick, Roxana Maria, et al.
Publicado: (2022) -
Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosis
por: Korfei, Martina, et al.
Publicado: (2018)